Table 1 Distribution of patients with CR and non CR at different cut-off values of polyglutamylation percentage
From: Clinical significance of polyglutamylation in primary central nervous system lymphoma
CR | No CR | p | |
|---|---|---|---|
1% of cut-off value | |||
Polyglutamylation, ≧ 1% (n = 48) | 26 | 22 | |
Non polyglutamylation, <  1% (n = 34) | 12 | 22 | 0.091a |
10% of cut-off value | |||
Polyglutamylation, ≧ 10% (n = 43) | 25 | 18 | |
Non polyglutamylation, <  10% (n = 39) | 13 | 26 | 0.025a |
20% of cut-off value | |||
Polyglutamylation, ≧ 20% (n = 28) | 16 | 12 | |
Non polyglutamylation, <  20% (n = 54) | 22 | 32 | 0.16a |
30% of cut-off value | |||
Polyglutamylation, ≧ 30% (n = 24) | 13 | 11 | |
Non polyglutamylation, <  30% (n = 58) | 25 | 33 | 0.36a |